» Articles » PMID: 36810603

Mutation in Smek2 Regulating Hepatic Glucose Metabolism Causes Hypersarcosinemia and Hyperhomocysteinemia in Rats

Overview
Journal Sci Rep
Specialty Science
Date 2023 Feb 22
PMID 36810603
Authors
Affiliations
Soon will be listed here.
Abstract

Suppressor of mek1 (Dictyostelium) homolog 2 (Smek2), was identified as one of the responsible genes for diet-induced hypercholesterolemia (DIHC) of exogenously hypercholesterolemic (ExHC) rats. A deletion mutation in Smek2 leads to DIHC via impaired glycolysis in the livers of ExHC rats. The intracellular role of Smek2 remains obscure. We used microarrays to investigate Smek2 functions with ExHC and ExHC.BN-Dihc2 congenic rats that harbor a non-pathological Smek2 allele from Brown-Norway rats on an ExHC background. Microarray analysis revealed that Smek2 dysfunction leads to extremely low sarcosine dehydrogenase (Sardh) expression in the liver of ExHC rats. Sarcosine dehydrogenase demethylates sarcosine, a byproduct of homocysteine metabolism. The ExHC rats with dysfunctional Sardh developed hypersarcosinemia and homocysteinemia, a risk factor for atherosclerosis, with or without dietary cholesterol. The mRNA expression of Bhmt, a homocysteine metabolic enzyme and the hepatic content of betaine (trimethylglycine), a methyl donor for homocysteine methylation were low in ExHC rats. Results suggest that homocysteine metabolism rendered fragile by a shortage of betaine results in homocysteinemia, and that Smek2 dysfunction causes abnormalities in sarcosine and homocysteine metabolism.

References
1.
Drobny A, Meloh H, Wachtershauser E, Hellmann B, Mueller A, Van der Klis J . Betaine-rich sugar beet molasses protects from homocysteine-induced reduction of survival in Caenorhabditis elegans. Eur J Nutr. 2019; 59(2):779-786. DOI: 10.1007/s00394-019-01944-3. View

2.
Hoffmann L, Brauers G, Gehrmann T, Haussinger D, Mayatepek E, Schliess F . Osmotic regulation of hepatic betaine metabolism. Am J Physiol Gastrointest Liver Physiol. 2013; 304(9):G835-46. DOI: 10.1152/ajpgi.00332.2012. View

3.
Chao C, McKnight K, Cox K, Chang A, Kim S, Feldman B . Novel GATA6 mutations in patients with pancreatic agenesis and congenital heart malformations. PLoS One. 2015; 10(2):e0118449. PMC: 4338276. DOI: 10.1371/journal.pone.0118449. View

4.
Sreekumar A, Poisson L, Rajendiran T, Khan A, Cao Q, Yu J . Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009; 457(7231):910-4. PMC: 2724746. DOI: 10.1038/nature07762. View

5.
Altarejos J, Montminy M . CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol. 2011; 12(3):141-51. PMC: 4324555. DOI: 10.1038/nrm3072. View